CIRS, mould exposure and the nervous system
Chronic inflammatory response syndrome (CIRS): symptoms, mould exposure and support
Chronic inflammatory response syndrome, or CIRS, is a term used by some clinicians to describe persistent symptoms attributed to exposure to water-damaged buildings, mould or other environmental substances.
People reporting these symptoms may experience fatigue, difficulty thinking, pain, respiratory symptoms, sleep disruption or increased sensitivity to their surroundings. These experiences can be significant and deserve careful assessment.
However, CIRS is not universally accepted as an established medical diagnosis, and there is continuing debate about its proposed causes, diagnostic tests and treatment protocols. Damp and mouldy buildings are associated with recognised health risks, but they do not provide one explanation for every persistent or multisystem symptom.
This page explores what is established, what remains uncertain and where nervous-system support may fit alongside appropriate medical and environmental care.
Understanding the terminology
CIRS is a proposed framework, not a universally accepted diagnosis
Some clinicians use CIRS to describe a multisystem pattern of symptoms attributed primarily to water-damaged buildings or other environmental exposures.
There is no single internationally accepted definition, diagnostic test or treatment pathway for CIRS. Major medical organisations recognise that damp and mouldy environments can affect health, while questioning whether indoor mycotoxin exposure explains the broad collection of systemic symptoms sometimes labelled CIRS.1, 7
Established
Damp and mouldy buildings are associated with respiratory symptoms, asthma, allergies, hypersensitivity pneumonitis and some other health effects. 1 , 3 , 9
Proposed
The CIRS model proposes that some people develop a persistent multisystem inflammatory response following certain environmental exposures. 14
Still uncertain
The proposed biomarkers, genetic susceptibility model, broad symptom clusters and standard CIRS treatment protocols have not achieved universal clinical acceptance. 7
Uncertainty about a diagnosis does not make symptoms imaginary. People experiencing persistent or changing symptoms deserve to be heard, assessed and supported.
The evidence base
What is established about dampness and mould
Visible mould or persistent dampness indicates a moisture problem that should be corrected. The strongest established evidence concerns respiratory and allergic effects, and individual responses differ.1, 2, 9, 10
Recognised effects may include:
- nasal and eye irritation;
- coughing or wheezing;
- worsening asthma;
- allergic rhinitis;
- eczema or skin irritation;
- respiratory infections in some circumstances;
- hypersensitivity pneumonitis in susceptible individuals;
- invasive fungal infection in people who are significantly immunocompromised.
The strongest evidence concerns respiratory and allergic effects. Evidence is less certain for the wide range of neurological, hormonal, digestive and systemic symptoms often attributed to “toxic mould syndrome” or CIRS.1, 7, 9, 10
What people may notice
Symptoms people may report
Persistent fatigue
Reduced stamina or ongoing tiredness that does not fully lift with rest.
Brain fog
Difficulty concentrating, slower processing or word-finding difficulty.
Headaches or dizziness
Recurrent headaches, light-headedness or a sense of disequilibrium.
Muscle and joint discomfort
Aches or discomfort affecting muscles or joints.
Disturbed sleep
Sleep may be disrupted or feel unrefreshing.
Respiratory or sinus symptoms
Nasal, sinus or breathing symptoms, particularly in damp environments.
Sensitivity to smells or environments
Stronger reactions to odours, chemicals or particular places.
Mood changes or feeling on alert
Anxiety, low mood or a sense of being constantly watchful.
These symptoms are not specific to mould exposure or CIRS. They may occur for many different reasons, and their presence alone cannot confirm either.
They can occur with many medical conditions, medication effects, sleep disorders, allergies, respiratory illness, migraine, anaemia, thyroid disease, ME/CFS, post-infectious conditions, persistent pain and psychological distress.
Keeping the picture wide
Why symptoms require a wider assessment
Because these symptoms overlap with so many conditions, attributing them to a single cause too early can mean other treatable explanations are missed.
A careful assessment keeps several possibilities open at once, rather than assuming mould or CIRS from the start.
Overlapping conditions
Sleep disorders, thyroid disease, anaemia, allergy, migraine and other conditions can produce a similar picture.
More than one factor
Someone may have a verified environmental problem and a separate medical condition at the same time.
Changing over time
Symptoms that shift or spread deserve review rather than a fixed early label.
Getting the full picture
There is no single accepted test for CIRS
An assessment should begin with:
- a detailed symptom and medical history;
- when and where symptoms occur;
- relevant home or workplace dampness;
- respiratory, allergy and infection history;
- medications and existing diagnoses;
- physical examination where appropriate;
- established medical testing guided by symptoms.
Tests sometimes used within CIRS practice
Visual contrast sensitivity (VCS) testing, HLA typing and markers such as C4a, TGF-beta-1, MMP-9, MSH and VIP do not independently confirm CIRS and are not part of a universally accepted diagnostic pathway. They may be affected by other conditions and should not be described as confirming mould-related illness.7, 16
Urine mycotoxin testing has not been established as a diagnostic test for illness caused by indoor mould exposure. ERMI was developed as a research tool and is not recommended by the EPA for routine home health assessment.3, 6
New or changing symptoms deserve assessment
New, severe or changing symptoms should not automatically be attributed to mould or CIRS. A qualified healthcare professional should consider other possible explanations.
Addressing the environment
Address confirmed moisture and mould problems using established guidance
- visible mould and dampness should be addressed;
- water leaks and moisture sources should be repaired;
- porous materials may sometimes need removal;
- larger or recurring problems may require a qualified remediation professional;
- people with significant respiratory disease, mould allergy or immune suppression should not undertake extensive mould cleanup themselves.
CDC and NIOSH state that routine air sampling is not generally recommended for evaluating whether a building is safe, because there are no health-based indoor mould standards and short-term samples may not reflect actual exposure. Visual inspection, moisture assessment and correction of dampness are often more useful.4, 5, 6
Addressing dampness does not mean you must immediately leave your home, discard all belongings or move to a completely “toxin-free” environment.
Support depends on the clinical picture
Support depends on the person and the clinical picture
Treat recognised conditions
Asthma, allergy, infection, migraine, sleep disorders and other identified conditions require appropriate evidence-based care.
Reduce ongoing dampness or exposure
Correct verified moisture and mould problems using proportionate environmental guidance.
Support individual symptoms
Treatment may address sleep, pain, respiratory symptoms, fatigue, dizziness, anxiety or other specific difficulties.
Rehabilitation and emotional support
Support should reflect the person’s health, current capacity and goals.
Prescription binders and specialist protocols
Some specialist clinicians use protocols that include prescription binders such as cholestyramine. Evidence for these protocols is limited and debated, and these medicines can cause adverse effects and interactions. Treatment decisions must be made by an appropriately qualified prescriber.16
A wider nervous-system picture
Persistent illness can affect how the nervous system responds
Living with persistent symptoms, disrupted sleep, uncertainty and repeated symptom flares can affect attention, confidence and how strongly someone responds to bodily sensations or environmental cues.
This does not determine the original cause of the symptoms, and it does not mean mould exposure or physical symptoms are psychological. It means that biological illness, environment, sleep, attention, stress and learned responses can interact.
Body sensations
Fatigue, pain, dizziness or breathlessness may become closely associated with fear or anticipation.
Environmental cues
Particular places, smells or buildings may start to trigger a strong protective response.
Uncertainty and scanning
Not knowing the cause can keep attention focused on possible danger.
Repeated protective responses
Patterns of bracing, avoidance or alarm can become familiar through repetition.
CIRS and neuroplasticity
Where neuroplasticity-based practice may fit
Neuroplasticity is the brain and nervous system’s ability to change through learning, experience and repetition. For some people living with persistent symptoms or environmental sensitivity, structured practice may help them respond with less alarm, work with symptom-related fear, improve regulation and rebuild confidence gradually.
This is supportive care. Neuroplasticity does not remove mould, eradicate infection, bind toxins, diagnose CIRS or prove that symptoms are psychological. It should not replace environmental remediation, medical assessment or treatment for an identified condition.
✕a cure for CIRS;
✕a mould-remediation method;
✕a way to detoxify the body;
✕evidence that symptoms are imagined;
✕a replacement for medical care;
✕a guarantee of recovery.
The re-origin approach
Support for working with persistent nervous-system patterns
re-origin provides science-informed neuroplasticity programs, brain-body practices, coaching and community support for nervous-system regulation.
Some members use the platform alongside medical and environmental care to understand repeated patterns, create more space around difficult sensations and practise steadier responses in everyday life.
re-origin does not diagnose or treat CIRS, mould illness, allergy, infection or toxic exposure.
Understand patterns
Explore how symptoms, attention, stress, uncertainty and repeated responses may interact.
Practise regulation
Practise responding to difficult sensations with less immediate fear or urgency.
Build confidence gradually
Use short, repeatable practices that can be adapted around current capacity.
Practise with support
Access structured programs, guided practices, coaching and moderated member communities.
Community
Personal experiences from the re-origin community
These stories describe individual experiences. They are not clinical evidence, do not establish the cause of another person’s symptoms and do not predict a typical outcome.
Julie’s experience with mould exposure
What are limbic-system retraining exercises?
Nervous-system regulation for stress, health and resilience
Understanding limbic-system dysfunction
Julie’s experience with mould exposure, pain and fatigue
Angela’s experience with mould, Lyme disease and persistent symptoms
Katie Rapkoch, CHPC
Biography & credentials to be confirmed before publication
Katie Rapkoch is the author of this article and has contributed to re-origin’s neuroplasticity education. Her confirmed title, credentials, biography, photograph and profile link will be added before publication.
Last updated: July 2026 · Last medically reviewed: pending clinical sign-off
The final medical reviewer’s name, qualification and review date will appear here as a separate credited card once an appropriately qualified reviewer has approved the final page.
Related topics
Related symptoms and experiences
ME/CFS and chronic fatigue
Post-exertional malaise, unrefreshing sleep and a substantial loss of capacity.
Chronic Lyme disease and PTLDS
Persistent symptoms after Lyme disease and how PTLDS differs from active infection.
Central sensitization
Increased responsiveness in pain-processing pathways and what it does and does not mean.
Multiple chemical sensitivity
Strong reactions to smells, chemicals or particular environments.
Brain fog and cognitive fatigue
Concentration, memory, processing and word-finding difficulties.
Sleep difficulties
Unrefreshing sleep, disrupted sleep and the relationship between rest and capacity.
Questions
Questions about CIRS and mould exposure
What does CIRS stand for?
CIRS most commonly stands for chronic inflammatory response syndrome. It is a term used by some clinicians to describe persistent multisystem symptoms attributed to exposure to water-damaged buildings, mould or other environmental substances.
Is CIRS a recognised medical diagnosis?
CIRS is not universally accepted as an established medical diagnosis. There is no single internationally agreed definition, diagnostic test or treatment pathway, and there is continuing debate about its proposed causes and protocols.
Can damp or mouldy buildings affect health?
Yes. Damp and mouldy indoor environments are associated with recognised effects such as nasal and eye irritation, coughing, wheezing, worsening asthma and allergic rhinitis, and more serious effects in some susceptible people. Visible mould or persistent dampness should be corrected.
Does mould cause fatigue or brain fog?
The strongest evidence for mould concerns respiratory and allergic effects. Evidence is less certain for the wide range of neurological and systemic symptoms sometimes attributed to mould. Fatigue and brain fog have many possible causes and should be assessed individually.
Is there a definitive test for CIRS?
No. There is no single accepted test that confirms CIRS. Some tests used within CIRS practice are not universally accepted as diagnostic and may be affected by other conditions.
Do urine mycotoxin tests diagnose mould illness?
Urine mycotoxin tests do not prove that a building caused a person’s symptoms and are not accepted as a way to diagnose mould-related illness. Results should be interpreted cautiously with a qualified professional.
Can genetic testing confirm CIRS?
No. HLA genetic typing is sometimes used within CIRS practice, but it does not prove an inability to clear biotoxins and does not independently confirm CIRS.
Should I have my home tested for mould?
Routine air sampling is not generally recommended, because there are no health-based indoor mould standards and short-term samples may not reflect real exposure. Visual inspection, moisture assessment and correcting dampness are often more useful.
Do I need to move out of my home?
Not necessarily. Verified moisture and mould problems should be corrected with proportionate guidance. You should not feel you must immediately leave your home or discard all belongings based on this page alone.
What type of doctor should I speak to?
Start with a qualified healthcare professional such as a GP or primary-care doctor, who can assess symptoms, consider other explanations and refer to respiratory, allergy or other specialists where appropriate.
Is cholestyramine an established CIRS treatment?
Some specialist clinicians use protocols that include prescription binders such as cholestyramine. Evidence for these protocols is limited and debated, and these medicines can cause adverse effects and interactions. Treatment decisions must be made by an appropriately qualified prescriber.
Can neuroplasticity cure CIRS?
No. Neuroplasticity does not remove mould, eradicate infection, bind toxins or cure CIRS. It may be one supportive way to work with nervous-system regulation and symptom-related alarm alongside appropriate medical and environmental care.
Can re-origin treat mould illness?
No. re-origin does not diagnose or treat CIRS, mould illness, allergy, infection or toxic exposure. It provides science-informed neuroplasticity programs, brain-body practices, coaching and community support for nervous-system regulation.
Support designed to meet you where you are
Science-informed neuroplasticity programs, practices, coaching, and community for nervous system regulation. Built by people who’ve lived it. Designed to meet you where you are. Carried by community.
Medical disclaimer
The information on this page is provided for educational purposes only. It is not intended to diagnose, treat, cure or prevent any condition and does not replace assessment, diagnosis or treatment from qualified healthcare professionals. Do not start, stop or change medication or treatment based on this page. Seek appropriate medical advice for new, severe, worsening or unexplained symptoms.
References
- World Health Organization. WHO Guidelines for Indoor Air Quality: Dampness and Mould. 2009. WHO. View source
- Institute of Medicine. Damp Indoor Spaces and Health. National Academies Press. 2004. National Academies. View source
- Centers for Disease Control and Prevention. Mold: Possible Health Effects. CDC (accessed July 2026). View source
- CDC / NIOSH. Health Problems Associated With Damp Buildings and Mold. CDC/NIOSH (accessed July 2026). View source
- CDC / NIOSH. Mold, Testing and Remediation. CDC/NIOSH (accessed July 2026). View source
- United States Environmental Protection Agency. Mold and Health. EPA (accessed July 2026). View source
- American Academy of Allergy, Asthma & Immunology. Toxic Mold Syndrome: Separating Fact From Fiction. AAAAI (accessed July 2026). View source
- American College of Medical Toxicology. Medical Toxicology Considerations in the Diagnosis and Treatment of Patients With Concerns About Mold-Related Inhalation Exposures. 2025. ACMT position statement. View source
- Mendell MJ, Mirer AG, Cheung K, Tong M, Douwes J. Respiratory and allergic health effects of dampness, mold and dampness-related agents: a review of the epidemiologic evidence. Environmental Health Perspectives. 2011;119(6):748–756. Journal source. View source
- Caillaud D, Leynaert B, Keirsbulck M, Nadif R. Indoor mould exposure, asthma and rhinitis: findings from systematic reviews and recent longitudinal studies. European Respiratory Review. 2018;27:170137. Journal source. View source
- Park JH, Cox-Ganser JM, Rao C, Kreiss K. Respiratory inflammatory responses among occupants of a water-damaged office building. Indoor Air. 2008;18(2):92–99. Journal source. View source
- Cox-Ganser JM, Park JH. NIOSH Dampness and Mold Assessment Tool: documentation and data analysis. Buildings. 2022;12(8):1075. Journal source. View source
- Shoemaker RC, House DE. A time-series study of sick building syndrome: chronic, biotoxin-associated illness from exposure to water-damaged buildings. Neurotoxicology and Teratology. 2005;27(1):29–46. PubMed. View source
- Shoemaker RC, House DE. Sick building syndrome and exposure to water-damaged buildings: time-series study, clinical trial and mechanisms. Neurotoxicology and Teratology. 2006;28(5):573–588. PubMed. View source
- Shoemaker RC, House D, Ryan JC. Structural brain abnormalities in patients with inflammatory illness acquired following exposure to water-damaged buildings: a volumetric MRI study using NeuroQuant. Neurotoxicology and Teratology. 2014;45:18–26. Journal source. View source
- Dooley M, Vukelic A, Jim L. Chronic inflammatory response syndrome: a review of the evidence of clinical efficacy of treatment. Annals of Medicine and Surgery. 2024;86(12):7248–7254. Journal source. View source